Chapter 2 Discussion After reading Chapter 2 (pages 25-27) in your ebook, discuss how pharmacogenomics affects drug response in people. Also, construct a concept map to illustrate how pharmacogenomics affects drug response in people with various illnesses. Use the articles attached below to support your response. https://www.mdpi.com/2073-4425/13/2/311 https://visme.co/blog/how-to-make-a-concept-map/ Book | Abrams’ Clinical Drug Therapy: Rationales […]
Write a speech on the public service announcement (PSA) about ethical issues related to pharmacogenomics.
public service announcement (PSA) about ethical issues related to pharmacogenomics. Write a speech on the public service announcement (PSA) about ethical issues related to pharmacogenomics. Create a 2-minute video regarding ethical issues related to pharmacogenomics. The speech to be one page. You must include three reputable references (at least one must be an article).
What differences/concerns are noted with regard to psychotropic use with Black, Latino, and White youth?
After reading the articles by Le Cook et al. (2017) and Ninnemann (2012), discuss the following points: What differences/concerns are noted with regard to psychotropic use with Black, Latino, and White youth? What are pharmacogenomics and ethnopsychopharmacology, and what are their relevance to prescribing psychology? Be specific.
Discuss the differences between first-generation antipsychotics (FGA) and second-generation antipsychotics (SGA).
Please discuss the differences between first-generation antipsychotics (FGA) and second-generation antipsychotics (SGA). Include relevant pharmacodynamics and pharmacokinetics and the implications of each. Include the concepts of receptor affinity, binding, and potency. Please see below peers paper and create a response First‐generation antipsychotics (FGAs), are significantly effective in decreasing symptoms, but unfavorable effects, such as extrapyramidal […]